Nargess Arandi

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 6

Top Venues

Cancer immunology, immunotherapy : CII

Annals of hematology

International journal of immunogenetics

International journal of laboratory hematology

Hematology Research Center, Shiraz University of Medical Sciences, Shiraz-Iran: Shiraz, Fars, Iran

School of Public Health, Tehran University of Medical Sciences (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Hematology Research Center, Shiraz University of Medical Sciences, Shiraz-Iran: Shiraz, Fars, Iran

Iran

Assistant Professor

Education History

School of Public Health, Tehran University of Medical Sciences

Iran

PHD :: Pathobiology

Publications

Nargess Arandi, Omid Reza Zekavat, Negin Shokrgozar, Amin Shahsavani, Hossein Golmoghaddam, Mehdi Kalani
Altered frequency of FOXP3 + regulatory T cells is associated with development of inhibitors in patients with severe hemophilia A. International journal of laboratory hematology (2023)
Negin Shokrgozar, Mehdi Dehghani, Hossein Golmoghaddam, Mohamad Moghadam, Narges Rezaei, Vida Moayed, Nargess Arandi
The prognostic significance of immune checkpoint receptor expression in patients with lymphoma: Association with disease status and clinical outcomes. Asia-Pacific journal of clinical oncology 18 (5) (2022)
Negin Shokrgozar, Mehran Karimi, Hossein Golmoghaddam, Narges Rezaei, Vida Moayed, Sedigheh Sharifzadeh, Nargess Arandi
Expression of the immune checkpoint receptors CTLA-4, LAG-3, and TIM-3 in β-thalassemia major patients: correlation with alloantibody production and regulatory T cells (Tregs) phenotype. Annals of hematology 100 (10) (2021)
Mehdi Dehghani, Negin Shokrgozar, Mani Ramzi, Mehdi Kalani, Hossein Golmoghaddam, Nargess Arandi
The impact of selenium on regulatory T cell frequency and immune checkpoint receptor expression in patients with diffuse large B cell lymphoma (DLBCL). Cancer immunology, immunotherapy : CII 70 (10) (2021)
Ali Alavianmehr, Marzieh Mansouri, Mani Ramzi, Masoumeh Faghih, Ahmad Monabati, Nargess Arandi, Zahra Faghih, Shirin Farjadian
Association of killer-cell immunoglobulin-like receptor genes with acute myelogenous leukaemia. International journal of immunogenetics 47 (6) (2020)
Mehdi Dehghani, Mehdi Kalani, Hossein Golmoghaddam, Mani Ramzi, Nargess Arandi
Aberrant peripheral blood CD4+ CD25+ FOXP3+ regulatory T cells/T helper-17 number is associated with the outcome of patients with lymphoma. Cancer immunology, immunotherapy : CII 69 (9) (2020)

Nargess Arandi.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Nargess Arandi